The DOI matches its Crossref record; 219 of the 222 references it cites were found in a registry or an index.
Unveiling the genetic and epigenetic landscape of colorectal cancer: new insights into pathogenic pathways
Abstract
Colorectal cancer (CRC) is a complex disease characterized by genetic and epigenetic alterations, playing a crucial role in its development and progression. This review aims to provide insights into the emerging landscape of these alterations in CRC pathogenesis to develop effective diagnostic tools and targeted therapies. Genetic alterations in signaling pathways such as Wnt/β-catenin, and PI3K/Akt/mTOR are pivotal in CRC development. Genetic profiling has identified distinct molecular subtypes, enabling personalized treatment strategies. Epigenetic modifications, including DNA methylation and histone modifications, also contribute to CRC pathogenesis by influencing critical cellular processes through gene silencing or activation. Non-coding RNAs have emerged as essential players in epigenetic regulation and CRC progression. Recent research highlights the interplay between genetic and epigenetic alterations in CRC. Genetic mutations can affect epigenetic modifications, leading to dysregulated gene expression and signaling cascades. Conversely, epigenetic changes can modulate genetic expression, amplifying or dampening the effects of genetic alterations. Advancements in understanding pathogenic pathways have potential clinical applications. Identifying genetic and epigenetic markers as diagnostic and prognostic biomarkers promises more accurate risk assessment and early detection. Challenges remain, including validating biomarkers and developing robust therapeutic strategies…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Dysregulation of ncRNAs, such as miRNAs and lncRNAs, can lead to altered drug sensitivity and resistance in CRC cells [60].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [60]
Citations
Cites
Gene regulation by long non-coding RNAs and its biological functions
Statello, L., Guo, C.-J., Chen, L.-L., & Huarte, M. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00315-9 · Cited by 4,991
Microsatellite Instability in Colorectal Cancer
Boland, C. R., & Goel, A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.064 · Cited by 2,456
Roles of the immune system in cancer: From tumor initiation to metastatic progression
Gonzalez, H., Hagerling, C., & Werb, Z. (2018) · Genes & Development · doi:10.1101/gad.314617.118 · Cited by 2,111
Role of hypoxia in cancer therapy by regulating the tumor microenvironment
Jing, X., Yang, F., Shao, C., Wei, K., Xie, M., Shen, H., & Shu, Y. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1089-9 · Cited by 2,054 · cited 1×
“Targeting hypoxia-related pathways holds promise in overcoming therapy resistance and improving treatment outcomes in CRC [165].”
BackgroundTumor angiogenesis: causes, consequences, challenges and opportunities
Lugano, R., Ramachandran, M., & Dimberg, A. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03351-7 · Cited by 1,986
Immunotherapy in colorectal cancer: Rationale, challenges and potential
Ganesh, K., Stadler, Z. K., Cercek, A., Mendelsohn, R. B., Shia, J., Segal, N. H., & Diaz, L. A. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0126-x · Cited by 1,954
Targeting PI3K/Akt signal transduction for cancer therapy
He, Y., Sun, M. M., Zhang, G. G., Yang, J., Chen, K. S., Xu, W. W., & Li, B. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00828-5 · Cited by 1,892
Molecular Genetics of Colorectal Cancer
Fearon, E. R. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130235 · Cited by 1,805
Li, H., Yang, Y., Hong, W., Huang, M., Wu, M., & Zhao, X. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0089-y · Cited by 1,715
Targeting PI3K in cancer: mechanisms and advances in clinical trials
Yang, J., Nie, J., Ma, X., Wei, Y., Peng, Y., & Wei, X. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0954-x · Cited by 1,520
Research works printed but not linked: 10
- Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Gastroenterol Rev/Przegląd Gastroenterologiczny. 2019;14:89–103.
- Abbasi, W.; French, C.E.; Rockowitz, S.; Kenna, M.A.; Eliot Shearer, A. Evaluation of copy number variants for genetic hearing loss: a review of current approaches and recent findings. Human Genetics 2022, 1–14.
- Mueller D, Győrffy B. DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer. Biochimica et Biophysica Acta (BBA). 2022;1877:188722.
- Ali A, Ahmad E, Verma R, Sahu P, Nimisha; Srivastava, S., Saluja, S.S. Identification of therapeutic targets of gallbladder cancer using multi-omics approach. Brief Funct Genom. 2023;22:109–22.
- Dotolo S, Esposito Abate R, Roma C, Guido D, Preziosi A, Tropea B, Palluzzi F, Giacò L, Normanno N. Bioinformatics: from NGS data to biological complexity in variant detection and oncological clinical practice. Biomedicines. 2022. https://doi.org/10.3390/biomedicines10092074. · DOI
- Bian J, Dannappel M, Wan C, Firestein R. Transcriptional regulation of Wnt/β-catenin pathway in colorectal cancer. Cells. 2020. https://doi.org/10.3390/cells9092125. · DOI · Paper page
- Ortiz-Barahona V, Joshi RS, Esteller M. Use of DNA methylation profiling in translational oncology. Semin Cancer Biol. 2022;83:523–35. https://doi.org/10.1016/j.semcancer.2020.12.011. · DOI
- Lizardo DY, Kuang C, Hao S, Yu J, Huang Y, Zhang L. Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: From bench to bedside. Biochem Biophys Acta. 2020;1874:188447.
- Armaghany T, Wilson JD, Chu Q, Mills G. Genetic alterations in colorectal cancer. Gastrointest Cancer Res. 2012;5:19–27.
- Testa U, Pelosi E, Castelli G. Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells. J Med Sci. 2018;6:31.
Cited by
Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer
Haynes, J., & Manogaran, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051988 · Cited by 82
“Dysregulation of ncRNAs, such as miRNAs and lncRNAs, can lead to altered drug sensitivity and resistance in CRC cells [60].”
Exploring Potential Epigenetic Biomarkers for Colorectal Cancer Metastasis
Ajithkumar, P., Vasantharajan, S. S., Pattison, S. T., McCall, J. L., Rodger, E. J., & Chatterjee, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020874 · Cited by 27
Inflammasomes in Intestinal Disease: Mechanisms of Activation and Therapeutic Strategies
Scalavino, V., Piccinno, E., Giannelli, G., & Serino, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313058 · Cited by 13
Colorectal cancer mortality is associated with low selenoprotein P status at diagnosis
Brezina, S., Chillon, T. S., Asaad, S., Maieron, A., Prosenz, J., Seelig, J., Demircan, K., Hughes, D. J., Gsur, A., & Schomburg, L. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103701 · Cited by 13
Epigenetic dysregulation in glioblastoma: potential pathways to precision medicine
Prakash, V., & Gabrani, R. (2024) · Neurogenetics · doi:10.1007/s10048-024-00793-5 · Cited by 12
Metadata
- Authors
- Postwala, H., Shah, Y., Parekh, P. S., & Chorawala, M. R.
- Affiliations
- Gujarat University (IN)
- Corresponding author
- Chorawala, Mehul R.
- Venue
- Medical Oncology
- Published
- 2023-10-19
- Volume
- 40
- Issue
- 11
- Pages
- 334-334
- ISSN
- 1357-0560 (ISSN-L)
- 1559-131X
- OpenAlex
- W4387765740
- Cited by
- 26
- References
- 222
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 7
- FWCI
- 1.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Medical Oncology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- colorectal cancer, genetic alterations, epigenetic modifications, Wnt/β-catenin signaling, PI3K/AKT/mTOR pathway, DNA methylation, histone modifications, non-coding RNA, molecular subtypes, biomarkers, tumor progression, gene silencing, targeted therapy
- MeSH terms
- Humans, Colorectal Neoplasms, Biomarkers, Gene Expression Regulation, Neoplastic, DNA Methylation, Phosphatidylinositol 3-Kinases, Epigenesis, Genetic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Unveiling the genetic and epigenetic landscape of colorectal cancer: new insights into pathogenic pathways. https://app.cochat.ai/papers/10.1007/s12032-023-02201-8
- The paper
- Postwala, H., Shah, Y., Parekh, P. S., & Chorawala, M. R. (2023). Unveiling the genetic and epigenetic landscape of colorectal cancer: new insights into pathogenic pathways. Medical Oncology. https://doi.org/10.1007/s12032-023-02201-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.